MEG delta mapping along the healthy aging-alzheimer's disease continuum: Diagnostic implications

Journal of Alzheimer's Disease

Volumn 35, Issue 3, 2013, Pages 495-507

  Fernández, Alberto ^a,b   Turrero, Agustín ^a   Zuluaga, Pilar ^a   Gil Gregorio, Pedro ^c   Del Pozo, Francisco ^b   Maestu, Fernando ^a,b   Moratti, Stephan ^a,b  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b TECHNICAL UNIVERSITY OF MADRID   (Spain)

^c HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

Alzheimer's disease; delta mapping; magnetoencephalography; mild cognitive impairment

Indexed keywords

BIOLOGICAL MARKER;

ADULT; AGED; AGING; ALZHEIMER DISEASE; ARTICLE; BRAIN MAPPING; BRAIN REGION; COGNITIVE DEFECT; CONTROLLED STUDY; DELTA RHYTHM; DEMENTIA; DISEASE COURSE; DISEASE SEVERITY; HUMAN; MAGNETOENCEPHALOGRAPHY; MAJOR CLINICAL STUDY; NERVE DEGENERATION; NEUROPHYSIOLOGY; OCCIPITAL CORTEX; POSTERIOR PARIETAL CORTEX; PRECUNEUS; PRIORITY JOURNAL; SYNAPTIC TRANSMISSION;

EID: 84880219057     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-121912     Document Type: Article

References (47)

1. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDAWork Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939-944.
2. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CRJr, Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, Mohs RC, Morris JC, Rossor MN, Scheltens P, Carrillo MC, Thies B,Weintraub S, Phelps CH (2011) The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7, 263-269.
3. Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, Delacourte A, Galasko D, Gauthier S, Jicha G,Meguro K, O'Brien J, Pasquier F, Robert P, Rossor M, Salloway S, Stern Y, Visser PJ, Scheltens P (2007) Research criteria for the diagnosis of Alzheimer's disease: Revising the NINCDS-ADRDA criteria. Lancet Neurol 6, 734-746.
4. Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust WJ, Petersen RC, Snyder PJ, Carrillo MC, Thies B, Phelps CH (2011) The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7, 270-279.
5. Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, Iwatsubo T, Jack CR, Kaye J, Montine TJ, Park DC, Reiman EM, Rowe CC, Siemers E, Stern Y, Yaffe K, Carrillo MC, Thies B, Morrison-Bogorad M, Wagster MV, Phelps CH (2011) Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7, 280-292.
6. Dubois B, Feldman HH, Jacova C, Cummings JL, Dekosky ST, Barberger-Gateau P, Delacourte A, Frisoni G, Fox NC, Galasko D, Gauthier S, Hampel H, Jicha GA, Meguro K, O'Brien J, Pasquier F, Robert P, Rossor M, Salloway S, Sarazin M, de Souza LC, Stern Y, Visser PJ, Scheltens P (2010) Revising the definition of Alzheimer's disease: A new lexicon. Lancet Neurol 9, 1118-1127.
7. Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, Nordberg A, Backman L, Albert M, Almkvist O, Arai H, Basun H, Blennow K, de Leon M, DeCarli C, Erkinjuntti T, Giacobini E, Graff C, Hardy J, Jack C, Jorm A, Ritchie K, van Duijn C, Visser P, Petersen RC (2004) Mild cognitive impairment-beyond controversies, towards a consensus: Report of the International Working Group on Mild Cognitive Impairment. J Intern Med 256, 240-246.
8. Hughes JR, John ER (1999) Conventional and quantitative electroencephalography in psychiatry. J Neuropsychiatry Clin Neurosci 11, 190-208.
9. Riekkinen P, Buzsaki G, Riekkinen PJr, Soininen H, Partanen J (1991) The cholinergic system and EEG slow waves. Electroencephalogr Clin Neurophysiol 78, 89-96.
10. Riekkinen PJr, Sirvio J, Riekkinen P (1990) Relationship between the cortical choline acetyltransferase content and EEG delta-power. Neurosci Res 8, 12-20.
11. Soininen H, Partanen J, Laulumaa V, Helkala EL, Laakso M, Riekkinen PJ (1989) Longitudinal EEG spectral analysis in early stage of Alzheimer's disease. Electroencephalogr Clin Neurophysiol 72, 290-297.
12. Prichep LS (2007) Quantitative EEG and electromagnetic brain imaging in aging and in the evolution of dementia. Ann N Y Acad Sci 1097, 156-167.
13. Jeong J (2004) EEG dynamics in patients with Alzheimer's disease. Clin Neurophysiol 115, 1490-1505.
14. de Haan W, Stam CJ, Jones BF, Zuiderwijk IM, van Dijk BW, Scheltens P (2008) Resting-state oscillatory brain dynamics in Alzheimer disease. J Clin Neurophysiol 25, 187-193.
15. BerendseHW,Verbunt JP, Scheltens P, van DijkBW, Jonkman EJ (2000) Magnetoencephalographic analysis of cortical activity in Alzheimer's disease: A pilot study. Clin Neurophysiol 111, 604-612.
16. Osipova D, Ahveninen J, Jensen O, Ylikoski A, Pekkonen E (2005) Altered generation of spontaneous oscillations in Alzheimer's disease. Neuroimage 27, 835-841.
17. Lehtovirta M, Partanen J, Kononen M, Soininen H, Helisalmi S, Mannermaa A, Ryynanen M, Hartikainen P, Riekkinen P (1996) Spectral analysis ofEEGin Alzheimer's disease: Relation to apolipoprotein E polymorphism. Neurobiol Aging 17, 523-526.
18. Osipova D, Ahveninen J, Kaakkola S, Jaaskelainen IP, Huttunen J, Pekkonen E (2003) Effects of scopolamine on MEG spectral power and coherence in elderly subjects. Clin Neurophysiol 114, 1902-1907.
19. Jelic V, Johansson SE, Almkvist O, Shigeta M, Julin P, Nordberg A, Winblad B, Wahlund LO (2000) Quantitative electroencephalography in mild cognitive impairment: Longitudinal changes and possible prediction of Alzheimer's disease. Neurobiol Aging 21, 533-540.
20. Huang C, Wahlund L, Dierks T, Julin P, Winblad B, Jelic V (2000) Discrimination of Alzheimer's disease and mild cognitive impairment by equivalent EEG sources: Across-sectional and longitudinal study. Clin Neurophysiol 111, 1961-1967.
21. Fernandez A, Maestu F, Amo C, Gil P, Fehr T,Wienbruch C, Rockstroh B, Elbert T, Ortiz T (2002) Focal temporoparietal slow activity in Alzheimer's disease revealed by magnetoencephalography. Biol Psychiatry 52, 764-770.
22. Fernandez A, Arrazola J, Maestu F, Amo C, Gil-Gregorio P, Wienbruch C, Ortiz T (2003) Correlations of hippocampal atrophy and focal low-frequency magnetic activity in Alzheimer disease: Volumetric MR imagingmagnetoencephalographic study. AJNR Am J Neuroradiol 24, 481-487.
23. Fernandez A, Turrero A, Zuluaga P, Gil P, Maestu F, Campo P, Ortiz T (2006) Magnetoencephalographic parietal delta dipole density in mild cognitive impairment: Preliminary results of a method to estimate the risk of developing Alzheimer disease. Arch Neurol 63, 427-430.
24. Jensen O, Vanni S (2002) A new method to identify multiple sources of oscillatory activity from magnetoencephalographic data. Neuroimage 15, 568-574.
25. Lobo A, EzquerraV(1979) El mini-examen cognoscitivo: Un test sencillo y pr'actico para detectar alteraciones intelectivas en pacientesm'edicos. Actas Luso-Espa?nolas Psiquiatr Psicol M'ed 3, 189-202.
26. Reisberg B, Ferris SH, de Leon MJ, Crook T (1982) The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry 139, 1136-1139.
27. Yesavage JA(1997) Development and validation of a geriatric depression screening scale: A preliminary report. J Psychiatr Res 17, 37-49.
28. PetersenRC(2004) Mild cognitive impairment as a diagnostic entity. J Intern Med 256, 183-194.
29. Hauk O (2004) Keep it simple: A case for using classical minimum norm estimation in the analysis of EEG and MEG data. Neuroimage 21, 1612-1621.
30. Collins DL, Zijdenbos AP, Kollokian V, Sled JG, Kabani NJ, Holmes CJ, Evans AC (1998) Design and construction of a realistic digital brain phantom. IEEE Trans Med Imaging 17, 463-468.
31. Sarvas J (1987) Basic mathematical and electromagnetic concepts of the biomagnetic inverse problem. Phys Med Biol 32, 11-22.
32. Blair RC, Karniski W (1993) An alternative method for significance testing of waveform difference potentials. Psychophysiology 30, 518-524.
33. Gloor P, Ball G, Schaul N (1977) Brain lesions that produce delta waves in the EEG. Neurology 27, 326-333.
34. Bozzali M, Falini A, Franceschi M, Cercignani M, Zuffi M, Scotti G, Comi G, Filippi M (2002) White matter damage in Alzheimer's disease assessed in vivo using diffusion tensor magnetic resonance imaging. J Neurol Neurosurg Psychiatry 72, 742-746.
35. Hirono N, Kitagaki H, Kazui H, Hashimoto M, Mori E (2000) Impact of white matter changes on clinical manifestation of Alzheimer's disease: A quantitative study. Stroke 31, 2182-2188.
36. Hansen LA, DeTeresa R, Davies P, TerryRD(1988) Neocortical morphometry, lesion counts, and choline acetyltransferase levels in the age spectrum of Alzheimer's disease. Neurology 38, 48-54.
37. Soininen H, Riekkinen P, Partanen V, Paakonen A, Helkala E, Laulumaa V (1990) EEG in the diagnosis of early Alzheimer disease. In Alzheimer Disease Current Research and Early Diagnosis, Becker R, Giacobini E, eds. Taylor and Francis, New York, pp. 159-169.
38. Neufeld MY, Rabey MJ, Parmet Y, Sifris P, Treves TA, Korczyn AD (1994) Effects of a single intravenous dose of scopolamine on the quantitative EEG in Alzheimer's disease patients and age-matched controls. Electroencephalogr Clin Neurophysiol 91, 407-412.
39. Holschneider DP, Leuchter AF, Walton NY, Scremin OU, Treiman DM (1997) Changes in cortical EEG and cholinergic function in response to NGF in rats with nucleus basalis lesions. Brain Res 765, 228-237.
40. Holschneider DP,Waite JJ, Leuchter AF,WaltonNY, Scremin OU(1999) Changes in electrocortical power and coherence in response to the selective cholinergic immunotoxin 192 IgGsaporin. Exp Brain Res 126, 270-280.
41. Morbelli S, Piccardo A,Villavecchia G, Dessi B, Brugnolo A, Piccini A, Caroli A, Frisoni G, Rodriguez G, Nobili F (2010) Mapping brain morphological and functional conversion patterns in amnestic MCI: A voxel-based MRI and FDG-PET study. Eur J Nucl Med Mol Imaging 37, 36-45.
42. Devanand DP, Mikhno A, Pelton GH, Cuasay K, Pradhaban G, Dileep Kumar JS, Upton N, Lai R, Gunn RW, Libri V, Liu X, van Heertum R, Mann JJ, Parsey RV (2010) Pittsburgh compound B [11C-PIB] and fluorodeoxyglucose [18 F-FDG] PET in patients with Alzheimer disease, mild cognitive impairment, and healthy controls. J Geriatr Psychiatry Neurol 23, 185-198.
43. Mintun MA, Larossa GN, Sheline YI, Dence CS, Lee SY, Mach RH, Klunk WE, Mathis CA, DeKosky ST, Morris JC (2006) [11C]PIB in a nondemented population: Potential antecedent marker of Alzheimer disease. Neurology 67, 446-452.
44. Buckner RL, Snyder AZ, Shannon BJ, LaRossa G, Sachs R, Fotenos AF, Sheline YI, Klunk WE, Mathis CA, Morris JC, Mintun MA (2005) Molecular, structural, and functional characterization of Alzheimer's disease: Evidence for a relationship between default activity, amyloid, and memory. J Neurosci 25, 7709-7717.
45. Fouquet M, Desgranges B, Landeau B, Duchesnay E, Mezenge F, de la Sayette V, Viader F, Baron JC, Eustache F, ChetelatG(2009) Longitudinal brain metabolic changes from amnestic mild cognitive impairment to Alzheimer's disease. Brain 132, 2058-2067.
46. McKeeAC,AuR, Cabral HJ,KowallNW, Seshadri S,Kubilus CA, Drake J,Wolf PA (2006) Visual association pathology in preclinical Alzheimer disease. J Neuropathol Exp Neurol 65, 621-630.
47. Patwardhan MB, McCrory DC, Matchar DB, Samsa GP, Rutschmann OT (2004) Alzheimer disease: Operating characteristics of PET-a meta-analysis. Radiology 231, 73-80.